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Abstract 
Self-assembling cyclic peptide polymer nanotubes have emerged as a fascinating supramolecular 
system, well suited for a diverse range of biomedical applications. Due to their well-defined diameter, 
tunable peptide anatomy, and ability to disassemble in situ, they have been investigated as promising 
materials for numerous applications including biosensors, antimicrobials, and drug delivery. Despite 
this continuous effort, the underlying mechanisms of assembly and disassembly are still not fully 
understood. In particular, the exchange of units between individual assembled nanotubes has been 
overlooked so far, despite its knowledge being essential for understanding their behaviour in different 
environments. To investigate the dynamic nature of these systems, we synthesized cyclic peptide 
polymer nanotubes conjugated with complementary dyes, which undergo a Förster resonance energy 
transfer (FRET) in close proximity. Using model conjugates we were not only able to demonstrate 
that their self-assembly is highly dynamic and not kinetically trapped, but also that the self-assembly 
of the conjugates is strongly influenced by both solvent and concentration. Additionally, the 
versatility of the FRET system allowed us to study the dynamic exchange of these systems in 
mammalian cells in vitro using confocal microscopy, demonstrating the exchange of subunits between 
assembled nanotubes in the highly complex environment of a cell.  
Introduction 
Since the discovery of natural supramolecular polymers,[1] whereby the manipulation of chemistry on 
a molecular level can influence the formation of larger more versatile structures, there has been a 
drive to replicate such systems synthetically. For this reason, many synthetic self-assembling systems, 
which utilise non-covalent interactions, have culminated in the formation of an extraordinary library 
of nanoscale architectures such as nanofibers,[2] nanotubes,[3] nanorods,[4] and twisted nanoribbons.[5] 
Understanding these systems and predicting their behaviour is essential to maximising their potential 
for a diverse range of applications such as electronics,[6] bio-sensing[7] or drug delivery.[8] The 
fundamental nature of supramolecular polymer assemblies has been extensively studied by Meijer, 
Stupp and Aida.[9] Early work in this field differentiated between, isodesmic or cooperative self-
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assembly mechanisms.[10] The driving forces behind the formation and propagation of these 
assemblies typically includes hydrogen bonding, metal coordination, π-π stacking, inclusion 
complexes and Van der Waals, electrostatic and hydrophobic interactions.[11] For biological 
applications, a focus has been placed on replicating the hydrogen bonding interactions widely found 
in living systems, most notably in the structure of proteins.[12] Stupp et al. have studied the selective 
assembly and disassembly of self-assembling peptide amphiphiles, in different environments, that rely 
on both hydrogen bonding and hydrophobic interactions as driving forces of the assembly process.[2b] 
Exploiting the dynamic properties to depolymerise supramolecular systems, a feature many living 
systems use to provide vital biological functions,[13] is next challenge in mimicking the level of 
complexity exhibited in nature.  
 
Recently, attention has focused on designing supramolecular systems that are increasingly relevant for 
biomedical applications.[14] A highly versatile system in this context are self-assembling cyclic peptide 
(CP) nanotubes. The alternating D- and L- amino acid confirmation of the peptide leads to the 
formation of a flat disc-like structure. Perpendicular to the plane of the cyclic peptide ring the amide 
bonds participate in hydrogen bonding to form a nanotubular assembly.[3] These systems have gained 
much attention due to their potential biological applications as antimicrobial materials,[15] 
biosensors[16] and drug delivery vehicles.[17] Conjugation of water-soluble polymers to these peptides 
significantly improves their solubility, further widening the range of biological applications.[14b] As 
for most supramolecular structures, it remains unclear whether these self-assembled nanotubes are 
kinetically stable or are constantly exchanging subunits to reach a kinetic equilibrium. As this 
behaviour is of paramount importance to predict their performance in future in vitro and in vivo 
studies, an in-depth study of the dynamic nature of CP-polymer conjugates is critical. 
Herein, we designed CP-polymer conjugates modified with fluorescent dyes and used Förster 
resonance energy transfer (FRET) to probe the dynamic nature of the resulting nanotubes. 
Fluorescence is a powerful tool to study close intramolecular interactions and investigate the dynamic 
behaviour of supramolecular systems. [18] [19] In the context of cyclic peptides, Granja et al. previously 
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employed FRET to study the hydrogen-bonding interaction of small dimeric cyclic peptides.[20] In 
here, we propose to use FRET to gain an insight into the stacking of cyclic peptide nanotubes 
(CPNTs) in situ and provide vital information about the dynamics of these one-dimensional 
supramolecular structures. To gain a detailed understanding, key parameters such as solvent and 
concentration were varied, and their influence on the assembly process studied. In addition, the use of 
FRET allowed us to observe the behaviour of these nanotubes in mammalian cells in vitro, thus 
providing essential information about their dynamics in a complex biological environment.  
 
Results and Discussion 
Synthesis of cyclic peptide-polymer dye conjugate 
In order to investigate the dynamics of self-assembled cyclic peptide polymer nanotubes, a new class 
of dye conjugated peptides were synthesised. To infer information about the kinetic exchange of these 
systems, each cyclic peptide required the conjugation of a single FRET dye to its periphery. Using a 
‘bottom up’ approach, a sequence of amino acids was designed to yield an asymmetric cyclic peptide, 
which could be used to conjugate both a dye and polymer in an orthogonal manner. The bespoke 
asymmetric cyclic peptide (3, Scheme 1) used in this study, contained both an azide and amide moiety 
on its periphery (see Supplementary information, Figure S1 for details).  
Synthesis of the peptide was carried out via solid-phase peptide synthesis using Fmoc-deprotection 
chemistry. Cyclisation of the linear peptide into peptide 2 (Scheme 1, Figure S1) was then performed 
under dilute conditions to avoid intermolecular reactions. Full characterisation of these compounds 
can be found in the supplementary information (Figure S1-4). The attachment of the FRET dyes to the 
cyclic peptide was achieved via N-hydroxysuccinimide (NHS)-amine coupling. The efficiency of this 
step was assessed using High Pressure Liquid Chromatography (HPLC) and was shown to be 
quantitative, enabling the FRET emission to directly inform us of the exchange kinetics of the 
supramolecular system. Cyanine FRET dyes Cy3 and Cy5 were chosen as the FRET pair as their high 
extinction coefficients enables the detection of FRET at very low concentrations.[21] Additionally, the 
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spectral overlap of these dyes is ideal to avoid undesirable excitation of the acceptor. Characterisation 
of the dye-functionalised CP-polymer conjugates was done via HPLC equipped with ultraviolet (UV) 
and fluorescence detection (Supplementary information, Figure S7-8), as well as Electrospray 
Ionisation - Time of Flight (ESI-ToF) mass spectrometry (Supplementary information, Figure S4-5). 
A non-fluorescent conjugate was also synthesised as a control. For this conjugate to best mimic the 
self-assembly of the dye-functionalized conjugates, the free amine of the Lysine residue was 
converted to an amide group, by conjugation with valeric acid using the peptide coupling agent 
HATU (Scheme 1). The alkyl chain on the valeric acid replicates the alkyl linker on the NHS 
functionalised dyes. 
Conjugation of a water soluble polymer to the cyclic peptide helps to control the length of the tubular 
assembly and prevents lateral aggregation, in addition to improving the solubility of these otherwise 
insoluble nanotubes.[22] For this model system, a linear poly(ethylene glycol) (PEG 20 kg mol-1) end-
functionalized with an amine group was chosen. Using copper-free strain promoted alkyne-azide 
coupling,[23] the cyclic peptide conjugates were functionalised with a free NHS group, which was 
subsequently used to attach the amine-bearing PEG. HPLC and ESI-ToF analyses confirm the 
successful attachment of the linker and polymer after each step (Supplementary information, Figures 
S4-9). A simplified representation of the conjugation reactions is shown in Scheme 1 and detailed 
reaction scheme can be found in Figure S1. While the cyclic peptide alone is only soluble in DMSO, 
DMF and TFA, the CP-polymer conjugates proved to be soluble in a range of solvents such as water 
and toluene.  
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Scheme 1. Schematic representation of the synthesis of cyclic peptide-dye-polymer conjugates. 
Characterisation of the self-assembling cyclic peptide conjugates 
Hydrogen bonding between the amide bonds is known to drive the self-assembly of the CPNTs. 
However, the length of the formed nanotube can be influenced by number of different factors such as 
composition and position of the amino acids, as well as polymer grafting.[14b] Herein, the morphology 
of the resulting CP-polymer conjugates were analysed using small angle neutron scattering (SANS), 
Static Light Scattering (SLS) and Transmission Electron Microscopy (TEM).  
SANS is a powerful technique to characterise complex systems in order to understand any structural 
parameters, interactions, and changes due to environmental stimuli occurring in solution.[24] 
Previously, our group has used SANS to analyse a wide-range of CPNTs in different solvents, 
polymer conjugations, and in response to different stimuli (pH and temperature).[25] Here, SANS was 
used to confirm the formation of nanotubes for a mixture of conjugates 10 and 12, and to analyse how 
the presence of a fluorophore affected their stacking potential compared to the non-dye conjugated 
control (PEG-CP-Alkyl, 11).  
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Figure 1A shows the reduced, corrected scattering data for the control and the dye conjugated peptide 
system. From the fit, the length of each nanotube could be obtained. The data were initially fitted with 
either a cylinder or a core-shell cylinder model form factors, however, a statistically reliable fit was 
not obtained. As a result, a hairy-cylinder model was used that combines the form factors for a micelle 
with a rod-like core and attached flexible polymer chains, with a high degree of accuracy in both 
cases (Supplementary information, Figure S15). The core-radius has been shown to be 0.34 nm in 
previous studies and was used as a fixed parameter in the fitting process.[25a] From the values 
obtained, the number of aggregation (Nagg) can be determined by dividing the length of the tube by the 
distance between two single cyclic peptide unimers (0.47 nm), shown in Table 1.[25a, 26] Visually 
analysing the scattering profiles reveals a major difference in the Guinier region (q = 0.00416 - 0.01). 
Given that the Guinier region provides information on larger structures within the system, deviations 
here indicate nanotubes of different lengths. The control has a higher intensity at q-1, suggesting the 
formation of longer nanotubes, which is demonstrated in the fits. The scattering due to the dye-
conjugated peptide on the other hand exhibits a change in slope, thus suggesting tubes of a finite 
length exist. The length of the tubes was found to be 117 nm, compared to 89 nm for the control and 
mixed system, respectively. 
In addition to SANS, SLS experiments were used to determine the Nagg for the non-dye conjugated 
system in a range of concentrations (Figure S15). The dye conjugates could not be measured directly 
as the wavelength of the laser used for SLS (633nm) overlaps with the dye excitations (570nm and 
646nm for Cy3 and Cy5, respectively). The Nagg of non-dye conjugated system was then used as a 
floating variable in the fitting process.  
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Figure 1. A) Reduced SANS scattering data for the PEG-CP-Alkyl (Control) and (Premixed) PEG-
CP-Cy3 and PEG-CP-Cy5 system. The lines correspond to a fit to the hairy cylinder model. B) TEM 
image of cyclic peptide-polymer-dye conjugate (PEG-CP-Cy3) stained with UOAc. Distribution of 
nanotubular C) lengths and D) diameters extracted from TEM. 
Table 1. Summary on the characterisation of CPNTs using SANS and TEM. TEM values are 
represented as mean lengths and diameters ± standard deviation of 37  individual nanotubes. 
Sample Length 
(SANS)/ nm 
Nagg  
(SANS)/ nm 
Length  
(TEM)/ nm 
Nagg  
(TEM)/ nm 
Diameter 
(TEM)/ nm 
PEG-CP-Cy3 - - 85.0 (± 22.3) 180.9  7.1 (± 1.5) 
PEG-CP-Cy5 - - 81.8 (± 14.1) 174.0  8.4 (± 2.2) 
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The data presented here clearly confirm that both the control (PEG-CP-Alkyl) and mixed systems 
(PEG-CP-Cy3 and PEG-CP-Cy5) form long nanotubular aggregates of similar size in situ. 
Discrepancy in the sizes can be attributed the presence of bulky and charged dye (Cy3 or Cy5). Yet, 
the variation remains minor, possibly due to the distance between the dye and the cyclic peptide 
created by the linker.  
Using TEM the nanotubular morphology observed in SANS was independently confirmed. Samples 
were prepared from pure water (1 mg/mL) using the drop casting method. The low electron density of 
the peptide-dye-polymer conjugates made obtaining TEM images of these compounds very 
challenging, thus negative staining of samples dropcast on thin (4 nm) carbon-coated copper grids was 
used. Images are presented in Fig 1B. The formation of one-dimensional structures can be evidently 
seen for all three presented cyclic peptides (Figure 1B and S14). Upon statistical analysis of the TEM 
images using ImageJ, a very narrow distribution with a mean diameter of 7.1 nm was determined for 
PEG-CP-Cy3 (Figure 1D). This finding is consistent with the formation of single conjugated 
nanotubes. The diameter of the PEG-CP-Cy5 was relatively similar (mean diameter = 8.4 nm), 
however a larger value was obtained for PEG-CP-Alkyl (mean diameter = 15.5 nm). This could be 
associated to lateral aggregation upon removal of the solvent. The distribution of nanotube lengths 
was found to be wider (mean length = 85.0 nm for Cy3-peptide, and 81.8 nm for Cy5-peptide), which 
is to be expected in a self-assembled system (Figure 1C). Distribution for PEG-CP-Cy5 and PEG-CP-
Alkyl and can be found in Figure S14. 
PEG-CP-Cy3 and 
PEG-CP-Cy5 
(Premixed) 
89.0 189.3 - - - 
PEG-CP-Alkyl 116.9 248.8 117.7 (± 32.0) 250.4 15.5 (± 3.7) 
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Spectrochemical properties of dye conjugated cyclic peptides 
Following synthesis and characterisation, FRET was used to probe the dynamic nature of these 
supramolecular systems. The FRET emission of the acceptor dye (PEG-CP-Cy5) only occurs when 
specific requirements are met. Firstly, the emission spectra of the donor (PEG-CP-Cy3) should 
overlap with the absorption spectra of the acceptor enabling the fluorescence of the donor to excite the 
acceptor. The Cyanine dye FRET pair Cy3 and Cy5 typically fulfil these requisites and have been 
extensively used due to their high excitation coefficients, biocompatibility and ideal spectral 
overlap.[27] The absorption and emission spectra of PEG-CP-Cy3 and PEG-CP-Cy5 show that the 
conjugates conserve these properties (Figures S10-11). To reduce direct excitation of the acceptor dye 
in the subsequent FRET studies, which could also lead to acceptor emission, the donor was excited at 
500 nm instead of its absorption maxima. Secondly, FRET will only take place if the donor and 
acceptor (Cy3 and Cy5 respectively) are close enough in space for the energy transfer to take place, 
typically 10-100Å.[21, 28] The average distance between two CPs has previously been reported to be 
4.7Å and the pore diameter of the CP around 7.5 Å.[14b, 29] Therefore, an energy transfer for the 
presented system is expected if both dyes are incorporated into the same nanotube upon mixing. 
When these conditions are fulfilled, the energy transfer translates into a decrease in donor emission 
and an increase in the acceptor emission. 
Here, FRET studies were carried out by comparing a mixture of PEG-CP-Cy3 and PEG-CP-Cy5, and 
a mixture of the free dyes in solution (Cy3 and Cy5) as a control. Mixing the dyes alone resulted in no 
change in the emission spectra over 30 minutes, which can be attributed to the dyes being too far from 
one another in solution (Figure S18). In comparison, the emission of PEG-CP-Cy5 increased and the 
emission of PEG-CP-Cy5 decreased over time upon mixing (Figure 2B). This behaviour is indicative 
of the formation of FRET pairs, resulting from the exchange of monomer units or small segments of 
peptide between the formed nanotubes. The increase over time indicates that CPs dynamically 
exchange between different nanotubes to form increasingly mixed nanotubes, as no self-assembly and 
exchange would result in no FRET occurring. A schematic depiction of mixed cyclic peptide-
polymer-dye conjugates can be found in Figure 2A.  
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Figure 2. A) Schematic depiction of the FRET occurring in cyclic peptide nanotubes containing 
donor (Cy3) as well as acceptor (Cy5) dye molecules. B) Fluorescence donor and acceptor emission 
upon mixing the free dyes (Cy3 and Cy5) and the self-assembling dye conjugates (PEG-CP-Cy3 and 
PEG-CP-Cy5) in water. 
Solvent dependent dynamic unimer exchange of CPNT 
Using the FRET system outlined above we can further probe the dynamics of the dye conjugates 
(PEG-CP-Cy3 and PEG-CP-Cy5) in a range of different solvent environments. Our group has 
previously shown that cyclic peptides form shorter nanotubes in more hydrogen bond competitive 
solvents.[30] This is due to the solvent molecules competitively binding to the hydrogen bonding sites 
on the cyclic peptide required for stacking.  
In order to investigate these dynamics, stock solutions of PEG-CP-Cy3 (10) and PEG-CP-Cy5 (11) 
were made in DMF, water and toluene which have a range of different properties. Emission spectra, 
upon mixing the dye conjugates (PEG-CP-Cy3 and PEG-CP-Cy5) in a 1:1 volume ratio were taken at 
several different time intervals (Figure 3B) until a plateau was reached. Emission was then expressed 
as a FRET ratio, calculated using equation 1.[31]  
𝐸!"#.  =  !!!!!!! (1) 
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Where IA and ID are the total acceptor and donor fluorescence intensities respectively (Fig 3).  
Again, the change in emission associated with FRET (i.e. decrease in the donor and increase in the 
acceptor emission) was observed, with the exception of DMF, whereas in water and toluene a clear 
increase can be observed, showing FRET is occurring.  Interestingly, the rate at which FRET occurs 
appears to be different for both water and toluene (Fig 3C). In both solvents where conjugates are 
expected to assemble, the FRET ratio increases as a function of time, and therefore show the cyclic 
peptides dynamically exchanging to form progressively mixed nanotubes. This increase in FRET ratio 
eventually reaches a plateau whereby no further net mixing was observed and an equilibrium is 
maintained. The final FRET ratio of the equilibrium in different solvents clearly varies, and is 
postulated to be a result of the solvatochromic effects of the solvent, and/or the different lengths the 
nanotube assemblies. In addition, an insufficient exchange of CPs can lead to a lower final FRET 
ratio. The solvent dependent exchange kinetics were determined by modelling the increase in FRET 
ratio to a bi-exponential decay function, using OriginPro, providing two rate constants. A single 
exponential function yielded poor fits (R2 <0.9). Other FRET ratio kinetics in literature have also 
reported to require bi-functional models.[31a] This suggests that there are two different mixing 
processes occurring, an initial fast rate of mixing (K1) followed by a slower gradual exchange between 
assemblies (K2) until an equilibrium is reached. No rate constants could be determined for DMF as no 
increase over time was observed as the FRET ratio of < 0.l was reached instantaneously after mixing.  
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Figure 3. A) Schematic depiction of the FRET studies. Preassembled individual cyclic peptide-dye-
polymer conjugates in water (left) and a 1:1 mixture of both conjugates after the assemblies are left to 
dynamically exchange (right). B) Fluorescence emission spectra of PEG-CP-Cy3 and PEG-CP-Cy5 
upon mixing in water and C) Normalised FRET ratio of the mixed system in DMF, water and toluene. 
Toluene plateau was reached after 6 days (see Supplementary information, Figure S13). 
 
In a highly hydrogen competitive solvent such as dimethylformamide (DMF), mainly unimeric 
species or small aggregates were expected,[30] which is corroborated by the lack of change in FRET 
ratio upon mixing (Figure 3C), as they behave similarly to the non-assembling free dyes. The 
fluorescence emission of the donor stays obviously greater than the emission of the acceptor, lending 
itself to a low FRET ratio. In a disassembled/fully dynamic system the FRET ratio would not be 
expected to change. The FRET ratio observed remains constant, however it is not at zero due a small 
proportion of formed conjugates.  
In water, which is less hydrogen bond competitive than DMF, the solvent molecules can still compete 
with peptide-peptide hydrogen bonding, however to a far lesser extent than in DMF. The increase in 
FRET ratio (Figure 3C) shows that the dye conjugates are dynamically exchanging to form 
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increasingly mixed tubular aggregates. The plateau reached after 3 hours shows that no further net 
mixing occurs after this point (Figure 3C). 
Surprisingly, this dynamic behaviour was also observed in toluene where the solvent is not expected 
to compete with the hydrogen bond stacking sites of the CP. As expected, the rate at which they 
exchange is far slower than in water (7 days compared to 3 hours). In non-polar solvents the solvent 
molecules do not interact with the hydrogen bond sites on the cyclic peptide. For this reason, a slow 
rate of dynamics in toluene can be seen in both the kinetic rate constants (Table 2). As the solvent is 
able to interfere with hydrophibic interactions between CP, potentially weakening the connection, a 
possible mechanism for this is that the nanotubes are breaking at different positions and reform 
instead of the exchange of unimers.[32]  
The maximum FRET ratio was determined by measuring a premixed system. This was prepared by 
first separately dissolving each dye conjugate in DMF and then mixing them in a 1:1 ratio. The 
solvent was then evaporated and the residual CP conjugates were re-dissolved in water or toluene 
(Figure 4A). This ensured that the nanotubes formed in solution would be random supramolecular 
copolymers of both compounds. The minor difference observed between the maximum and final 
FRET ratio could be associated to the presence of small homogenous regions within the nanotubes. 
Table 2. The rate kinetics of the exchanging donor and acceptor conjugated cyclic peptide-polymer 
nanotubes. The final FRET ratio was the value at which the plateaux was reached.  
 
* The maximum FRET ratio was determined using a premixed sample dissolve in the respective solvent. See 
experimental section for details. 
Solvent K1/ s-1 K2/ s-1 Final 
FRET ratio 
Max 
FRET ratio* 
Degree of 
mixing/ % 
DMF - - 0.084 0.084 (100%) 
Water 96.12 3.80 0.729 0.810 90% 
Toluene 1.10 0.06 0.780 0.882 88% 
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The FRET ratio calculated for the free dyes in water was constant at 0.857 due to a small degree of direct 
excitation of the acceptor. Similarly in DMF, no emission change over time and a low FRET ratio indicates 
these conjugates resemble the free dyes and not aggregates. 
 
A theoretical FRET ratio of 1 would be expected if the dye conjugates formed statically mixed tubes 
of infinite length. Shown in Table 2, the final FRET ratios observed do not reach 1, therefore, 
suggesting the length of the aggregates formed, or the presence of unimers in solutions, prevents a 
quantitative exchange. 
Concentration dependency of CPNT self-assembly 
The described FRET system was also used to study the effect of concentration on the assembly of the 
CPNTs. Using the premixed system in water, vide supra, the solution was systematically diluted to 
observe the influence of concentration on the nanotube assembly. The fluorescence acceptor emission 
of this solution was measured upon excitation at 500 nm (donor) and 677nm (acceptor) independently. 
The FRET intensity was normalised against the maximum emission determined by direct excitation of 
the acceptor. As expected, the normalised FRET intensity decreased upon dilution (Figure 4B). 
Interestingly, at low concentrations, a plateau was reached, after which further dilution of the system 
showed no change in normalised FRET emission.  
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Figure 4. A) Fluorescence emission concentration dependent study of the mixed nanotubes. The 
concentration dependence on the cyclic peptide (premixed PEG-CP-Cy3 and PEG-CP-Cy5) stacking 
measured via B) fluorescence microscopy of the premixed dye conjugates and C) SLS of the control 
conjugates. 
Using static light scattering (SLS) the average molecular weight and Nagg of non-dye conjugates were 
studied in a similar concentration regime as the FRET study with the dye conjugates (Figure S16). 
This is corroborated by SANS which showed similar nanotubular lengths for the premixed dye and 
non-dye conjugates. A trend, whereby at lower concentrations a decrease in the number of 
aggregation, was observed in the SLS. It should be noted that these scattering experiments only yield 
relative information about these systems, as these values may be an effect of interactions between 
tubes at higher concentrations. Nevertheless, the relative observations of the polymerization process 
as observed from SLS supports the trend as obtained by FRET, whereby at lower concentrations 
smaller aggregates were formed (Figure 4C). Aggregation of the conjugates at lower concentrations 
could not be studied accurately using SLS due to insufficient intensity of scattered 
In vitro dynamic of cyclic peptide nanotubes 
Having characterised the dynamics of these model cyclic peptide-polymer conjugates in a controlled 
environment (i.e. pure water), we turned to studying their behaviour in a more complex setting, 
namely living biological systems. The peptides PEG-CP-Cy3 and PEG-CP-Cy5 were incubated in the 
presence of MDA-231 cells (human breast adenocarcinoma ) and fluorescence, including FRET-
associated fluorescence, was observed using fluorescent confocal microscopy. PEG-CP-Cy3 was used 
in a higher concentration (12 µM) than PEG-CP-Cy5 (4 µM) to account for the lower intensity as a 
result of not exciting the dye at its absorption maximum, resulting in a total concentration of 16 µM 
peptide. Negative controls whereby the cells were incubated individually with either PEG-CP-Cy3 or 
PEG-CP-Cy5 for 150 minutes clearly showed intracellular fluorescence when excited at their 
respective dye absorption and observed at their respective dye emission (Figure 5). The vast majority 
of the fluorescence can be observed in the intracellular region close to the nucleus, in a punctuated 
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design which indicates that the compounds have not diffused in the cytosol but remain trapped within 
the lysosomes instead. Endosomal uptake and subsequent localisation in the lysosomes is expected for 
such nanosized objects and has been demonstrated for similar structures.[33] 
When both PEG-CP-Cy3 10 and PEG-CP-Cy5 11 were co-injected and co-incubated in the presence 
of cells, allowing cyclic peptide-polymers to form mixed conjugates before or during cell entry, 
fluorescence associated with FRET could be observed within the cells. A similar result was observed 
when PEG-CP-Cy3 and PEG-CP-Cy5 where premixed in DMF, dried, re-dissolved in water, and 
injected in the cell culture. These results indicate that synthesised nanotubes of mixed conjugates can 
enter cells via endocytosis and remain intact within the harsh environment of the lysosomes for the 
time of the study.  
Next, we wanted to test whether individual CPs could form mixed conjugates within the complex 
environment of living cells. We hypothesized that PEG-CP-Cy3 and PEG-CP-Cy5 nanotubes 
incubated separately with the cells could, given enough time, mix within the restricted environment of 
the lysosomes. By incubating PEG-CP-Cy5 for 30 minutes, washing the cells thoroughly and further 
incubating with PEG-CP-Cy3 for 120 minutes, a significant increase in the intracellular fluorescence 
associated with FRET as compared to the control was observed (Figure 5E-F). This result clearly 
indicates that not only some of the nanotubes are transported into the same cell compartment but that 
the nanotubes are still able to exchange and re-organise themselves into mixed self-assembled systems 
within the cells. Given the low initial concentration of PEG-CP-Cy3/Cy3 and the small distance 
required for an energy transfer, this finding is very likely a result of co-stacking. Taken together, the 
data demonstrate that this self-assembling system is robust enough to maintain its shape within a 
biological environment whereas the dynamic character is preserved enabling difference species of 
nanotubes to communicate with each other via the exchange of unimers. The compatibility of these 
nanostructures with living cells highlights the potential of these compounds for future biological and 
biomedical applications.  
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Figure 5. Confocal microscopy imaging of MDA-231 cells incubated in the presence of either A) 
PEG-CP-Cy5 alone (4 µM); B) PEG-CP-Cy3 alone (12 µM); C) premixed PEG-CP-Cy5 (4 µM) and 
PEG-CP-Cy3 (12 µM); D) co-injected PEG-CP-Cy5 (4 µM) and PEG-CP-Cy3 (12 µM); E) PEG-CP-
Cy5 (4 µM) for 30 minutes, washed and PEG-CP-Cy3 (12 µM) for 120 minutes. Unless indicated 
otherwise, incubation proceeded for 150 min. Nucleus fluorescence was obtained using Hoechst 
33342. Excitation/Emission used for measurement are as follow, nucleus channel (405 / 406-459 nm), 
donor channel (517 / 540-577 nm), acceptor channel (633 / 670-724 nm), FRET (496 / 675-800 nm). 
F) Average intensity of intracellular fluorescence associated with FRET, as calculated using the mean 
of fluorescence in each cells for a minimum of 15 cells.  
Conclusion 
In this study, Förster Resonance Energy Transfer was used as a tool to demonstrate the dynamic 
behaviour of self-assembling cyclic peptide-polymer nanotubes in polar and non-polar environments. 
The same system was also used to study the aggregation at very low concentration as well as in the 
complex environment of living cells. Mixing the readily assembled nanotubes resulted in a time 
dependent increase in energy transfer associated with FRET, which proves that these supramolecular 
systems were readily exchanging units and are not kinetically trapped in various solvents of different 
polarity. Although in all cases near quantitative mixing is observed in comparison to premixed 
samples; the kinetics are much faster in aqueous solutions as compared to toluene. Further studies 
showed that upon dilution the fluorescence associated with the FRET decreased which is related to 
steady decrease in size of the aggregates, a trend confirmed via static light scattering. In complex 
environments such as living cells, the combination of FRET and confocal microscopy showed that the 
different nanotubes were independently transported into the same cell compartments addition of the 
individual FRET-dye conjugates. This ability to recombine even under such conditions as present in 
living cells makes these materials attractive as a basic system for tracking of transport pathways, 
especially as further ligands can easily be attached to the polymer chain. In general, the obtained 
results provide the first fundamental information about the dynamic nature of these promising 
supramolecular systems in a range of different environments and lay the basis for further investigation 
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on manipulating these dynamics and so far unanticipated applications of these nanotubes for example 
as sensor devices and biological trackers. 
Associated content 
Electronic supplementary information 
Experimental section 
Materials 
Fmoc-protected amino acids and coupling agents were purchased from Iris Biotech GmbH. Cyanine3 
NHS ester and Cyanine5 NHS ester were obtained from Lumiprobe GmbH, Germany. The amine 
functionalised PEG was purchased from Rapp Polymere. Pentanoic acid was purchased from Alfa 
Aesar (UK). 
All other chemicals stated were purchased from Sigma-Aldrich, (Gillingham, UK) unless otherwise 
stated. Solvents were purchased from several departmental suppliers – Honeywell, Fisher and Sigma 
Aldrich. 
 
Characterisation 
Nuclear magnetic resonance spectroscopy (NMR)  
1H NMR spectrum were measured using a Bruker DPX-300 or DPX-400 NMR spectrometer which 
operated at 300.13 and 400.05 MHz respectively. The residual solvent peaks were used as internal 
references. Deuterated trifluoroacetic acid (d-TFA) (δH = 11.5 ppm) was used to measure the peptides.  
 
Size-exclusion chromatography (SEC) / Gel permeation chromatography (GPC)  
GPC was measured using an Agilent PL50 instrument with a differential refractive index (DRI) 
detector. The instrument contained two PolarGel H columns (300 x 7.5 mm) and a PolarGel 5µm 
guard column. DMF with 0.1% LiBr additive was used as the eluent. The system ran at 1mg min-1 
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(50ºC), with an injection volume of 100 µL. The samples were prepared by filtering them through 
0.22 µm pore size membranes, before injection. Agilent EasyVial poly (methyl methacrylate) 
standards were used to calibrate the instrument and output data was analysed using Agilent GPC/SEC 
software.  
 
Small Angle Neutron Scattering (SANS) 
SANS was carried out on the Sans2d small-angle diffractometer at the ISIS Pulsed Neutron Source 
(STFC Rutherford Appleton Laboratory, Didcot, U.K.).[34]  A simultaneous Q-range of 0.0045 – 0.7 
Å-1 was achieved utilizing an incident wavelength range of 1.75 – 16.5 Å and employing an 
instrument set up of L1=L2=4m, with the 1 m2 detector offset vertically 60 mm and sideways 100 
mm.  Q is defined as: 
𝑄 = 4𝜋 sin 𝜃2𝜆                (2) 
 
where θ is the scattered angle and λ is the incident neutron wavelength.  The beam diameter was 8 
mm.  Each raw scattering data set was corrected for the detector efficiencies, sample transmission and 
background scattering and converted to scattering cross-section data (∂Σ/∂Ω vs. Q) using the 
instrument-specific software.[35] These data were placed on an absolute scale (cm-1) using the 
scattering from a standard sample (a solid blend of hydrogenous and perdeuterated polystyrene) in 
accordance with established procedures.[36] Conditions and experimental information can be found in 
the supplementary information, S17. 
 
Ultraviolet/visible (UV-Vis) absorption spectroscopy  
UV-Vis absorption spectra was measured using an Agilent Technologies Cary 60 UV-Vis 
spectrometer. The UV spectra of PEG-CP-Cy3 (10) and PEG-CP-Cy5 (11) were obtained in each 
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solvent (water, DMF, toluene). The solution were all made to the same concentration (35 µM). 
Spectra can be found in the supplementary information, Figure S10. 
 
Fluorescence emission spectroscopy  
Fluorescence emission spectra was measured using an Agilent Technologies Cary Eclipse 
Fluorescence spectrometer.  
The FRET studies were performed using an excitation wavelength of 500 nm. This was done to 
significantly reduce the direct excitation of the acceptor in the FRET studies. The acceptor emission 
upon excitation at 500 nm was considerably smaller than at 548nm (absorption maxima of the donor). 
See figures S10 and S11 in the supplementary information for the absorption and emission spectra, 
respectively, of the conjugates 10 and 11. 
Dynamics in self-assembled systems  
First, 35 µM stock solutions of PEG-CP-Cy3 and PEG-CP-Cy5 were prepared in the water. The 
emission spectra of the PEG-CP-Cy3 was measured before the addition of the PEG-CP-Cy5 
conjugate. The fluorescence emission spectra were taken using the Agilent Kinetic software. 
Excitation of the donor was set to 500 nm, donor emission (detected) to 565 nm and acceptor 
emission (detected) at 662 nm. The mixing of the dyes Cy3-NHS and Cy5-NHS were also tested 
using the same conditions. 
Solvent dependence study 
First, 35 µM stock solutions of PEG-CP-Cy3 and PEG-CP-Cy5 were prepared in the relevant solvent. 
The emission spectra of the PEG-CP-Cy3 was measured before the addition of the PEG-CP-Cy5 
conjugate. The fluorescence emission spectra were taken at several time points upon the addition of 
the PEG-CP-Cy5. The FRET ratio was obtained using the equation 1, the relative FRET intensities 
were calculated and fitted to a second order exponential function. 
Concentration dependence study 
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First, 50 µM stock solutions of PEG-CP-Cy3 and PEG-CP-Cy5 in DMF were prepared. 1 mL of each 
stock solution was added to a vial and the solution was shaken for 30 minutes and the solvent was 
evaporated. The residual solid was then redissolved in a precise volume of water (around 1 mL) to 
create a dye conjugate solution with a concentration of 100 µM. 1 mL of this solution was transferred 
to measure the first concentration (100 µM). Next, 1 mL of water was added to the cuvette to yield the 
next dilution (50 µM). For subsequent concentrations the solution in the cuvette was transferred to 
another vial and further dilution concentrations were made up in a new vial using 1 mL of water and 
1 mL of the transferred (previous) solution. 
 
High performance liquid chromatography (HPLC)  
High performance liquid chromatograms (HPLC) was measured using an Agilent Technologies 1200 
Series, equipped with a Luna 5u C18 100 Å, 250 x 4.6mm column. Acetonitrile/Water were used. All 
solvents contained 0.04 vol% TFA. Further information about the method and gradients can be found 
with the HPLC data in the supplementary information - Figure S3, S7~9. 
 
Mass spectrometry (ESI-TOF)  
Electronspray ionisation (ESI) – time of flight (TOF) mass spectra (MS) was measured using a Bruker 
MicroTOF to characterise the peptides and peptide conjugates. The instrument can achieve less than 
5 ppm mass accuracy. 
Static Light Scattering (SLS) 
The SLS data were obtained using the ALV/CGS-3 Compact Gonimeter System.  
A range of different concentrations of non-dye conjugated CP-polymers measured using SLS. The 
compounds were first accurately measured in a vial and corresponding volumes of water were added 
to yield various different concentrations (5 mg mL-1 - 0.2 mg mL- 1). Before measuring, the solutions 
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were filtered using 0.2 µM membrane PTFE lined filters to remove any large PEG crystalline 
aggregates. 
Confocal microscopy 
MDA-231 (human breast adenocarcinoma) cells were cultured in High Glucose DMEM medium 
supplemented with 10% fetal bovine serum. For confocal microscopy, MDA-231 cells were seeded in 
an 8-well ibidi plate at a density of 10 000 cells per well and allowed to grow for 48 hours prior to the 
experiment. Cells medium was then replaced by fresh medium and supplemented with PEG-CP-Cy5 
(4 µM), PEG-CP-Cy5 (12 µM), or both, from stock solutions at 200 µM in water. For the premixed 
sample, stock solutions of PEG-CP-Cy5 (200 µM) and PEG-CP-Cy5 (600 µM) were prepared in 
DMF, sonicated, DMF evaporated with N2 flow and re-dissolved in water. Cells were incubated with 
conjugates for 135 minutes. In the case of sequential incubation, PEG-CP-Cy5 (4 µM) was incubated 
first for 30 minutes, the cells washed thoroughly with PBS, then incubated with fresh media and PEG-
CP-Cy5 (12 µM) for 105 minutes. For all sample, Hoechst 33342 was then added and incubation 
proceeded for another 15 minutes before cells were washed with warm media twice. Confocal 
microscopy images were taken on a Leica TCS SP5 (Carl Zeiss, Germany) at a temperature of 37°C, 
using sequential scanning for each channel.  Excitation/Emission used for measurement are used as 
follow: nucleus channel (405 / 406-459 nm), donor channel (517 / 540-577 nm), acceptor channel 
(633 / 670-724 nm), FRET (496 / 675-800 nm). Average of fluorescence for each sample was 
measured using ImageJ software by isolating single cells as region of interest and averaging the mean 
of fluorescence in each cells, on a minimum of 15 cells by samples. 
Transmission Electron Microscopy (TEM)  
Carbon films (4 nm) were prepared on freshly cleaved mica sheets using a Quorum Q150T Turbo 
carbon coater. These films were deposited on copper TEM girds (mesh 400 – Agar Scientific) by 
flotation water. Solutions of PEG-CP-dye/alkyl conjugates in water at 1 mg mL-1 were prepared by 
direct dissolution of the solid in filtered ultra-pure water. Samples were left to age for 24h at room 
temperature then filtered through PTFE syringe filters (0.45 µm pore size). 10 µL of each solution was 
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drop-cast on freshly glow-discharged carbon-coated grids placed on filter paper. After drying, 10 µL 
of a 2% uranyl acetate solution in ethanol was dropped onto the grids on filter paper and left to dry. 
Bright field TEM micrographs were obtained with a JEOL 1400 microscope operating at 120 kV, 
equipped with a Gatan digital camera. 
 
Synthesis 
The synthesis of the cyclic peptide N3-CP-NH2 (3)and the azido-modified Fmoc-protected amino acid 
was synthesised. Standard deprotection solid phase peptide synthesis was used to first synthesis the 
protected linear peptide. Using a coupling agent the cyclisation was completed in dilute conditions to 
avoid intermolecular reactions. The insolubility of the stacked cyclic peptides in methanol was used to 
isolate the pure cyclic peptide. The cyclic peptide was then deprotected using TFA to reveal the amine 
of the lysine and azoles on the tryptophans. Characterisation of the linear peptide and cyclic peptide 
can be found in the supplementary information, S1.  
 
Conjugation of the dye to the cyclic peptide 
CP-Cy3 (4): The cyclic peptide 4 (20.0 mg, 1.66 x 10-5 mol, 1 eq.) was dissolved in DMF (0.5 mL) 
with the aid of sonication. To make certain the amine on the cyclic peptide was deprotected N,N-
Diisopropylethylamine (DIPEA) (10 mgmL-1 stock solution in DMF, 0.64ml of stock solution, 6.4 
mg, 4.98 x 10-5 mol, 3 eq.) was added. The solution was shaken for 30 minutes. The Cyanine3 NHS 
ester (11.6 mg, 1.99 x 10-5 mol, 1.2 eq.) was then added to the solution and shaken overnight. The 
product was purified via precipitation using THF. Yield: 67% (18.5mg, 1.12 x 10-5 mol). ESI-ToF, 
m/z (found) = 1644.9, (calculated) = 1645.0 ([M]+), see figure S4. HPLC (tR= 24 mins) using 
Acetonitrile/Water gradient. Spectra and gradient information can be found in the supplementary 
information, S7. 
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CP-Cy5 (5): CP-Cy5 (5) was synthesised using the same protocol as CP-Cy3 (4). Cyanine5 NHS 
ester was used instead of Cyanine3 NHS ester to synthesise 5. Yield: 29% (8.2 mg, 4.9 x 10-6 mol). 
ESI-ToF, m/z (found) = 1671.2, (calculated) = 1671.0 ([M]+), see figure S5. HPLC (tR= 24 mins) 
using Acetonitrile/Water gradient. Spectra and gradient information can be found in the 
supplementary information, S8. 
 
Conjugation of pentanoic acid to the cyclic peptide 
CP-Alkyl (6): Pentanoic acid (2.7 µL, 2.49 x 10-5 mol, 3 eq.), HCTU (10.3mg, 2.49 x 10-5 mol, 3 eq.) 
and N,N-Diisopropylethylamine (DIPEA) (6.43 mg, 4.97 x 10-5 mol, 6 eq.) were dissolved together in 
DMF (1 mL) and shaken for 10 minutes. The cyclic peptide 4 (10.0 mg, 8.29 x 10-6 mol, 1 eq.) was 
separately dissolved in DMF (0.5 mL) with the aid of sonication. The pentanoic acid mixture was then 
added to the cyclic peptide solution. The resultant solution was shaken for 3 hours. The product was 
purified via precipitation using ice-cold diethyl ether. Yield: 61% (4.68 mg, 1.12 x 10-5 mol). ESI-
ToF, m/z (found) = 1312.5, (calculated) = 1312.8 ([M+Na]+), see figure S6. Due to the insolubility of 
this compound HPLC was not possible. 
 
NHS functionalisation of the cyclic peptide conjugates (CP-Cy3, CP-Cy5 and CP-alkyl) 
NHS-CP-Cy3 (7): The CP-Cy3 (4) (18.5 mg) was dissolved in DMF (0.5 mL) with the aid of 
sonication. (1R,8S,9s)-Bicyclo[6.1.0]non-4-yn-9-ylmethyl N-succinimidyl carbonate (BCN-NHS) 
was added to the cyclic peptide solution. The resultant solution was shaken overnight. The product 
was purified via precipitation using ice-cold diethyl ether. Yield: 73% (17.8 mg, 9.19 x 10-6 mol). 
ESI-ToF, m/z (found) =1936.0, (calculated) = 1936.1 ([M]+), see figure S4. HPLC (tR= 22 mins) using 
Acetonitrile/Water gradient. Spectra and gradient information can be found in the supplementary 
information, S7. 
NHS-CP-Cy5 (8): NHS-CP-Cy5 (8) was synthesised using CP-Cy5 (5) and the same protocol as 
NHS-CP-Cy3 (7). Yield: 78% (7.9 mg, 4.0 x 10-6 mol). ESI-ToF, m/z (found) =1962.1, (calculated) = 
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1962.1 ([M]+), see figure S5. HPLC (tR= 22 mins) using Acetonitrile/Water gradient. Spectra and 
gradient information can be found in the supplementary information, S8. 
NHS-CP-Alkyl (9): NHS-CP-Alkyl (6) was synthesised using CP-Alkyl (6) and the same protocol as 
NHS-CP-Cy3 (7). Yield: 74% (4.1 mg, 2.6 x 10-6 mol). Due to the insolubility of this compound ESI-
ToF and HPLC was not possible. 
Conjugation of the polymer to the cyclic peptide 
PEG-CP-Cy3 (10): NHS-CP-Cy3 (7) (14mg) was dissolved in DMF (0.5mL) with the aid of 
sonication. α-Methoxy-ω-amino PEG 20 kDa (0.247 g, 1.08 x 10-5 mol, 1.5 eq.) was added to the 
cyclic peptide solution. To make certain the amine on the polymer was deprotected N,N-
Diisopropylethylamine (DIPEA) (10mg/mL stock solution in DMF, 0.24 ml of stock solution, 2.4 mg, 
1.4 x 10-5 mol, 2 eq.) was added. The solution was shaken overnight. The product was purified using 
centrifuge dialysis tubes with a molecular weight cut-off of 50kDa. Yield: 58% (101 mg, 4.21 x 10-6 
mol). HPLC (tR= 16 mins) using Acetonitrile/Water gradient. Spectra and gradient information can be 
found in the supplementary information, S7. 
PEG-CP-Cy5 (11): PEG-CP-Cy5 (11) was synthesised using NHS-CP-Cy5 (8) and the same protocol 
as PEG-CP-Cy3 (10). Yield: 67% (59.9 mg, 2.48 x 10-6 mol). HPLC (tR= 16 mins) using 
Acetonitrile/Water gradient. Spectra and gradient information can be found in the supplementary 
information, S8. 
PEG-CP-Alkyl (12): PEG-CP-Cy5 (12) was synthesised using NHS-CP-Alkyl (9) and the same 
protocol as PEG-CP-Cy3 (10). Yield: 56% (34.4 mg, 1.45 x 10-6 mol). HPLC (tR= 21 mins) using 
Acetonitrile/Water gradient. Spectra and gradient information can be found in the supplementary 
information, S9. 
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